Condition-specific health context in a specific context is closer to a research marker, so it should be read separately from a directly felt benefit.
Representative tier calculated from paper evidence that passed the collection audit.
The representative ingredient tier is calculated from these target-level evidence groups.
Disease-specific, biomarker, animal, or cell-study findings — not everyday felt benefits.
10 new papers were added in this period. No new risk signal was identified.
Standalone side-effect signals and combination cautions are listed separately.
The group showed a positive signal, but individual contributions are hard to isolate. Not a stack recommendation.
Paper IDs and full lists are private. Only study types and summaries are shown.
The importance of riboflavin and its efficient transmembrane transport in human physiology is outlined and recent work with different models of RTD that have revealed possible pathomechanisms contributing to neurodegeneration in patients are focused on.
The crucial role of riboflavin for general human health, and the clear benefits of rib oflavin treatment in patients with inborn errors of metabolism are described.
Treatment with a proprietary nutritional supplement containing magnesium, riboflavin and Q10 had an impact on migraine frequency which showed a trend towards statistical significance and Migraine symptoms and burden of disease were statistically significantly
The data demonstrate that riboflavin supplementation has a number of anti-inflammatory and anti-oxidant effects in CD, and this is the first study of its kind to demonstrate this.
The data show that riboflavin treatment improves complex I activity in the majority of patient-derived fibroblasts tested, and this effect was also reported for most of the treated patients and is mirrored in the survival data.
The findings suggest that prolonged exclusive breastfeeding may not provide sufficient B vitamins for small infants, and that this may have a negative effect on early gross motor development.